Eric Baldwin Email & Phone Number

Boston, Massachusetts, US

Small Molecule and Biologic Drug Discovery. Computational modeling, Crystallographic Structure determination and analysis. Biophysics and biochemical data to support drug discovery decisions and compound advancement.

• Partner with small molecule, antibody, and cell therapy drug discovery organizations. Project Management services and scientific consulting.
• Protein Design, Biophysics, Structure-Based Drug Design, Computational Chemistry.
• Biochemical and Cell Assay development, Target Biology Review and Assessment
• CRO identification and Management; Grant and Medical writing, Portfolio Management

Armonk, New York, NY, US

Senior Project Manager 2019-PresentManaging the delivery of stakeholder /Key Opinion Leader solutionsSolution Executive 2018-2019Helping customers in Pharmaceutical, Biotech and Academics use the power of Augmented Intelligence to drive scientific discovery.-Crafting cognitive solutions using diverse data sources: RWE, genomic, biochemical data.

New Brunswick, NJ, US

• Orchestrated execution of antibody drug discovery projects from concept to phase 1.
• Delivered Multiple Myeloma asset Teclistamab to phase 1 (2017) Clinical Evaluation ongoing
• Led revision and standardization of IND-supporting discovery document for Biologics Research (2016) new fit-for-purpose document, designed to facilitate FDA review.
• Provided vision for and implementation of EndNote Reference process for Electronic Lab Notebook (2015), achieving dramatic decrease in document preparation time.

• Served as scientific and financial point of contact for subcontractors. Represented NCI senior management’s interests and maintained transparency with stakeholders.
• Identified deficiencies in multi-center research program; created plan to address issues and influenced NCI leadership to take action; implemented plan and provided ongoing communication during change management.
• Resolved conflicts between multiple stakeholders across complex political and institutional boundaries, aligning team members focused on chemistry results.
• Obtained rapid fluency in new areas of cancer biology, re-defined drug discovery tactical objectives from academic research plans, and converted concepts to contractual language; preparing Request for Proposals (RFP).

• Advised clients to enable data-driven decision making by designing tactical solutions to early discovery challenges: Cardiovascular, Neurodegenerative Disorders, and Antibody-Drug Conjugates.
• Utilized scientific network and wrote grants to support client fundraising or Pharma diligence.+Senior Advisor, Serometrix LLC (2011-2014)+Senior Director, Business Development for The Chemistry Research Solution, Inc..

• Drove 5 selective integration initiatives that supported 50% expansion of team’s portfolio. Led IT projects that built comprehensive workflow and data management system for crystallography.
• Transformed team of 14 direct reports, over 50% PhDs, using metrics to support a culture of urgency.
• Decreased costs, dropped cycle time fourfold, and increased results delivered to stakeholders threefold without adding headcount by introducing process improvements and new technologies

• Created structure databank in collaboration with computational and chemistry colleagues.
• Led team of 9 direct reports, created interdependencies and built a matrix of working relationships that produced higher productivity and enhanced employee engagement.

• Protein Crystallography Team Leader/ Senior Research Advisor and Fellow V
• Led technical teams that tackled structural studies in cancer, immunology, infectious, central nervous system, cardiovascular and metabolic diseases.
• Determined first x-ray structures of numerous Staph drug targets and first drug complex with alpha-7 ion channel surrogate.
• Led team that solved first structure of Herpes virus polymerase.
• Developed industry leading structure workflow tools, structure web-pages, and structure overlay tools.
• Named one of the top 40 Pharmacia discovery scientists following the merger with Searle/Monsanto

Bethesda, MD, US

NIAID post-doctoral Fellowship to determine the structure of IL-8 and other chemokines. Determined numerous HIV protease drug complex structures and the structure of human cathepsin D.

Chapel Hill, NC, US

Crystallization and structure detemination of Manganese Catalase. Use of fractional factorial designs for protein crystallization. Dynamic light scattering as a predictive tool for protein crystallization.

Phd, Biochemistry

Bs, Biochemistry